11-3089889-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020896.4(OSBPL5):c.2458G>A(p.Glu820Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000134 in 1,565,816 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020896.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OSBPL5 | NM_020896.4 | c.2458G>A | p.Glu820Lys | missense_variant | 21/22 | ENST00000263650.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OSBPL5 | ENST00000263650.12 | c.2458G>A | p.Glu820Lys | missense_variant | 21/22 | 1 | NM_020896.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152114Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000230 AC: 4AN: 174008Hom.: 0 AF XY: 0.0000214 AC XY: 2AN XY: 93494
GnomAD4 exome AF: 0.0000120 AC: 17AN: 1413702Hom.: 0 Cov.: 31 AF XY: 0.0000129 AC XY: 9AN XY: 699118
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152114Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74300
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 27, 2023 | The c.2458G>A (p.E820K) alteration is located in exon 21 (coding exon 20) of the OSBPL5 gene. This alteration results from a G to A substitution at nucleotide position 2458, causing the glutamic acid (E) at amino acid position 820 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at